Oric Pharmaceuticals (ORIC) Stock: Buy, Sell, or Hold?
ORIC - Oric Pharmaceuticals, Inc. Common Stock
$12.35
-0.42 (-3.29%)
▼
5d:
+3.0%
30d:
-4.11%
90d:
+18.52%
BUY
HIGH Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Nov 12, 2026
23d
Get Alerted When ORIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ORIC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ORIC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ORIC is currently trading at $12.35, which is considered oversold relative to its 30-day fair value range of $11.94 to $13.12.
Technical Outlook: Technically, ORIC is in a strong uptrend. Immediate support is located at $10.93, while resistance sits at $12.89. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: ORIC scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.64 (+75.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ORIC is in a strong uptrend. Immediate support is located at $10.93, while resistance sits at $12.89. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: ORIC scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.64 (+75.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.94 -
$13.12
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 75.2% below Wall St target ($21.64)
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$11.94 -
$13.12
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$10.93
Resistance Level
$12.89
Current Trend
Strong Uptrend
Technical data as of
Oct 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.38
Wall Street Target
$21.64
(+75.2%)
Share & Embed Analysis
Last updated: October 19, 2026 2:18 AM ET
Data refreshes hourly during market hours. Next update: 3:18 AM
Data refreshes hourly during market hours. Next update: 3:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORIC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 48 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 43 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 53 HOLD |
|
LBRX
LB Pharmaceuticals Inc C… |
STRONG BUY
11 analysts |
$58 | 73 BUY |
